Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California
Shanghai Yunying Medical Technology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Siemens Molecular Imaging